FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220778147> ?p ?o ?g. }

• W4220778147 endingPage "45" @default.
• W4220778147 startingPage "37" @default.
• W4220778147 abstract "Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in the world, and has no radical treatment. Inhibition of amiloride-sensitive epithelial sodium ion channel (ENaC) has now been considered as a potential therapeutic target against COPD. One possible modulator of ENaC is AMP-activated protein kinase (AMPK), a key molecule that controls a wide variety of cellular signals; however, little is known about whether metformin, a clinically available AMPK activator, has a protective role against ENaC-associated chronic pulmonary phenotypes, such as emphysema and pulmonary dysfunction. We first used ENaC-overexpressing human bronchial epithelial cells (β/γENaC-16HBE14o-) and identified that Metformin significantly reduced ENaC activity. Consistently, in vivo treatment of ENaC-overexpressing COPD mouse model (C57BL/6-βENaC-Tg mice) showed improvement of emphysema and pulmonary dysfunction, without any detrimental effect on non-pulmonary parameters (blood glucose level etc.). Bronchoalveolar lavage fluid (BALF) and lung tissue analyses revealed significant suppression in the infiltration of neutrophils as well as the expression of inflammatory markers (KC), neutrophil gelatinase (MMP9) and macrophage elastase (MMP12) in metformin-treated C57BL/6-βENaC-Tg mice. Overall, the present study demonstrates that metformin directly inhibits ENaC activity in vitro and provides the first evidence of therapeutical benefit of Metformin for COPD with higher ENaC activity." @default.
• W4220778147 created "2022-04-03" @default.
• W4220778147 creator A5013537836 @default.
• W4220778147 creator A5019098775 @default.
• W4220778147 creator A5030457676 @default.
• W4220778147 creator A5040079401 @default.
• W4220778147 creator A5053300273 @default.
• W4220778147 creator A5053776224 @default.
• W4220778147 creator A5056023717 @default.
• W4220778147 creator A5059688088 @default.
• W4220778147 creator A5061541394 @default.
• W4220778147 creator A5063535019 @default.
• W4220778147 creator A5066726177 @default.
• W4220778147 creator A5068172204 @default.
• W4220778147 creator A5070508398 @default.
• W4220778147 creator A5080461359 @default.
• W4220778147 creator A5088100252 @default.
• W4220778147 date "2022-06-01" @default.
• W4220778147 modified "2023-10-14" @default.
• W4220778147 title "Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases" @default.
• W4220778147 cites W1495274944 @default.
• W4220778147 cites W1983563653 @default.
• W4220778147 cites W1987140385 @default.
• W4220778147 cites W1989880163 @default.
• W4220778147 cites W2008071158 @default.
• W4220778147 cites W2020620553 @default.
• W4220778147 cites W2022941489 @default.
• W4220778147 cites W2039746846 @default.
• W4220778147 cites W2105050951 @default.
• W4220778147 cites W2125428479 @default.
• W4220778147 cites W2140702220 @default.
• W4220778147 cites W2149309380 @default.
• W4220778147 cites W2179187436 @default.
• W4220778147 cites W2325466744 @default.
• W4220778147 cites W2566929387 @default.
• W4220778147 cites W2587278410 @default.
• W4220778147 cites W2777719338 @default.
• W4220778147 cites W2805718179 @default.
• W4220778147 cites W2806664701 @default.
• W4220778147 cites W2889170508 @default.
• W4220778147 cites W2923020714 @default.
• W4220778147 cites W3002978711 @default.
• W4220778147 cites W3037780936 @default.
• W4220778147 cites W3095600581 @default.
• W4220778147 cites W3151332571 @default.
• W4220778147 cites W3200848476 @default.
• W4220778147 doi "https://doi.org/10.1016/j.jphs.2022.03.002" @default.
• W4220778147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35512853" @default.
• W4220778147 hasPublicationYear "2022" @default.
• W4220778147 type Work @default.
• W4220778147 citedByCount "1" @default.
• W4220778147 countsByYear W42207781472023 @default.
• W4220778147 crossrefType "journal-article" @default.
• W4220778147 hasAuthorship W4220778147A5013537836 @default.
• W4220778147 hasAuthorship W4220778147A5019098775 @default.
• W4220778147 hasAuthorship W4220778147A5030457676 @default.
• W4220778147 hasAuthorship W4220778147A5040079401 @default.
• W4220778147 hasAuthorship W4220778147A5053300273 @default.
• W4220778147 hasAuthorship W4220778147A5053776224 @default.
• W4220778147 hasAuthorship W4220778147A5056023717 @default.
• W4220778147 hasAuthorship W4220778147A5059688088 @default.
• W4220778147 hasAuthorship W4220778147A5061541394 @default.
• W4220778147 hasAuthorship W4220778147A5063535019 @default.
• W4220778147 hasAuthorship W4220778147A5066726177 @default.
• W4220778147 hasAuthorship W4220778147A5068172204 @default.
• W4220778147 hasAuthorship W4220778147A5070508398 @default.
• W4220778147 hasAuthorship W4220778147A5080461359 @default.
• W4220778147 hasAuthorship W4220778147A5088100252 @default.
• W4220778147 hasBestOaLocation W42207781471 @default.
• W4220778147 hasConcept C126322002 @default.
• W4220778147 hasConcept C134018914 @default.
• W4220778147 hasConcept C178790620 @default.
• W4220778147 hasConcept C184235292 @default.
• W4220778147 hasConcept C185592680 @default.
• W4220778147 hasConcept C2776780178 @default.
• W4220778147 hasConcept C2777714996 @default.
• W4220778147 hasConcept C2777961210 @default.
• W4220778147 hasConcept C2779306644 @default.
• W4220778147 hasConcept C2780124434 @default.
• W4220778147 hasConcept C2780323712 @default.
• W4220778147 hasConcept C537181965 @default.
• W4220778147 hasConcept C55493867 @default.
• W4220778147 hasConcept C6507245 @default.
• W4220778147 hasConcept C71924100 @default.
• W4220778147 hasConcept C97029542 @default.
• W4220778147 hasConcept C98274493 @default.
• W4220778147 hasConceptScore W4220778147C126322002 @default.
• W4220778147 hasConceptScore W4220778147C134018914 @default.
• W4220778147 hasConceptScore W4220778147C178790620 @default.
• W4220778147 hasConceptScore W4220778147C184235292 @default.
• W4220778147 hasConceptScore W4220778147C185592680 @default.
• W4220778147 hasConceptScore W4220778147C2776780178 @default.
• W4220778147 hasConceptScore W4220778147C2777714996 @default.
• W4220778147 hasConceptScore W4220778147C2777961210 @default.
• W4220778147 hasConceptScore W4220778147C2779306644 @default.
• W4220778147 hasConceptScore W4220778147C2780124434 @default.
• W4220778147 hasConceptScore W4220778147C2780323712 @default.
• W4220778147 hasConceptScore W4220778147C537181965 @default.

• next